TLR8
Assets acting on this target.
- Class
- Toll-like receptor 8 (TLR8) agonist
By indication
TLR8 drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| TQA3810 | Sino Biopharmaceutical | Not recorded | Phase 2 | Phase 2 in Chronic Hepatitis B |
| CB06-036 | GlaxoSmithKline, Zhimeng Biopharma | Not recorded | Phase 1 | Phase 1 in Chronic Hepatitis B |